Unrelated hematopoietic stem cell transplantation for Cernunnos-XLF deficiency

被引:24
作者
Faraci, Maura [1 ,2 ]
Lanino, Edoardo [1 ,2 ]
Micalizzi, Concetta [1 ,2 ]
Morreale, Giuseppe [1 ,2 ]
Di Martino, Daniela [1 ,2 ]
Banov, Laura [1 ,2 ]
Comoli, Patrizia [3 ]
Locatelli, Franco [3 ]
Soresina, Annarosa [4 ,5 ]
Plebani, Alessandro [4 ,5 ]
机构
[1] G Gaslini Children Res Inst, Dept Hematol Oncol, I-16148 Genoa, Italy
[2] G Gaslini Children Res Inst, Hematopoiet Stem Cell Unit, I-16148 Genoa, Italy
[3] Univ Pavia, Policlin San Matteo, Fdn IRCCS, Lab Transplantat Immunol & Pediat Hematol Oncol, I-27100 Pavia, Italy
[4] Univ Brescia, Dept Pediat, Brescia, Italy
[5] Univ Brescia, Inst Mol Med A Nocivelli, Brescia, Italy
关键词
Cernunnos syndrome; hematopoietic stem cell transplantation; Epstein-Barr virus-post-transplantation lymphoproliferative disease; congenital immunodeficiency; BONE-MARROW-TRANSPLANTATION; STRAND BREAK REPAIR; LYMPHOPROLIFERATIVE DISEASE; CONDITIONING REGIMEN; IMMUNODEFICIENCY; CHILDREN;
D O I
10.1111/j.1399-3046.2008.01028.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Cernunnos-XLF deficiency is a rare CI characterized by a defective DNA DSB repair mechanism. Its clinical manifestations are growth retardation, dysmorphic features, malformations, and severe B- and T-cell lymphopenia. BM failure may complicate the clinical picture. To date, there have been no described patients with CSy undergoing allogeneic HSCT. We report a case of CSy treated successfully with unrelated allogeneic HSCT after a reduced-intensity conditioning regimen. Two yr after HSCT, the patient maintains full donor engraftment, normal hematopoiesis, and progressively improving immune competence, thus suggesting that HSCT may be the treatment of choice for CSy.
引用
收藏
页码:785 / 789
页数:5
相关论文
共 14 条
[1]   XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining [J].
Ahnesorg, P ;
Smith, P ;
Jackson, SP .
CELL, 2006, 124 (02) :301-313
[2]   Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly [J].
Buck, D ;
Malivert, L ;
de Chasseval, P ;
Barraud, A ;
Fondanèche, MC ;
Sanal, O ;
Plebani, A ;
Stéphan, JL ;
Hufnagel, M ;
le Deist, F ;
Fischer, A ;
Durandy, A ;
de Villartay, JP ;
Revy, P .
CELL, 2006, 124 (02) :287-299
[3]   EBV-related disease following haematopoietic stem cell transplantation with reduced intensity conditioning [J].
Cohen, Jonathan M. ;
Cooper, Nichola ;
Chakrabarti, Suparno ;
Thomson, Kirsty ;
Samarasinghe, Sujith ;
Cubitt, David ;
Lloyd, Cathryn ;
Woolfrey, Ann ;
Veys, Paul ;
Amrolia, Persis J. .
LEUKEMIA & LYMPHOMA, 2007, 48 (02) :256-269
[4]   Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation [J].
Comoli, P. ;
Basso, S. ;
Zecca, M. ;
Pagliara, D. ;
Baldanti, F. ;
Bernardo, M. E. ;
Barberi, W. ;
Moretta, A. ;
Labirio, M. ;
Paulli, M. ;
Furione, M. ;
Maccario, R. ;
Locatelli, F. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (06) :1648-1655
[5]   Treatment of EBV-related post-renal transplant lymphoproliferative disease with a tailored regimen including EBV-Specific T cells [J].
Comoli, P ;
Maccario, R ;
Locatelli, F ;
Valente, U ;
Basso, S ;
Garaventa, A ;
Tomà, P ;
Botti, G ;
Melioli, G ;
Baldanti, F ;
Nocera, A ;
Perfumo, F ;
Ginevri, F .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (06) :1415-1422
[6]   DNA double strand break repair and chromosomal translocation: Lessons from animal models [J].
Ferguson, DO ;
Alt, FW .
ONCOGENE, 2001, 20 (40) :5572-5579
[7]   The management of posttransplant lymphoproliferative disorder [J].
Frey, Noelle V. ;
Tsai, Donald E. .
MEDICAL ONCOLOGY, 2007, 24 (02) :125-136
[8]   Primary immunodeficiency syndromes associated with defective DNA double-strand break repair [J].
Gennery, A. R. .
BRITISH MEDICAL BULLETIN, 2006, 77-78 :71-85
[9]   Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome [J].
Gluckman, E. ;
Wagner, J. E. .
BONE MARROW TRANSPLANTATION, 2008, 41 (02) :127-132
[10]   The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group [J].
Locatelli, Franco ;
Zecca, Marco ;
Pession, Andrea ;
Morreale, Giuseppe ;
Longoni, Daniela ;
Di Bartolomeo, Paolo ;
Porta, Fulvio ;
Fagioli, Franca ;
Nobili, Bruno ;
Bernardo, Maria Ester ;
Messina, Chiara .
HAEMATOLOGICA, 2007, 92 (10) :1381-1388